RT @GEHealthcare: #COVID19 has hugely disrupted routine screening and elective procedures, including the treatment and diagnosis of cancer. With many patients concerned about the risks they face when seeking medical assistance, mobile diagnostics and monitoring devices are especially critical.
#COVID19 has hugely disrupted routine screening and elective procedures, including the treatment and diagnosis of cancer. With many patients concerned about the risks they face when seeking medical assistance, mobile diagnostics and monitoring devices are especially critical.
— GE Healthcare (@GEHealthcare) February 1, 2021
from Twitter https://twitter.com/GastonR48222321
February 02, 2021 at 08:15AM
Comentarios
Publicar un comentario